Orca Bio

Associate Director, Medical Information

Sacramento, California, United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

About Orca Bio

Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks. With our purified, high-precision investigational cell therapies we hope to not only replace patients' blood and immune systems with healthy ones, but also restore their lives.

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease.

About the Role

The Associate Director, Medical Information will report to the Vice President of Medical Affairs. You will be responsible for establishing a global medical information service at Orca Bio, be a leader in the Medical Affairs department, and be an integral team member in preparation for a commercial launch. You will be responsible to establishing the Medical Information service at Orca Bio, including set up and oversight of a Medical Information Call center.

Essential Duties & Key Responsibilities

  • Establish the Global Medical Information capability within Medical Affairs, creating and managing the Medical Information budget, setting up the structure, business processes and systems governing the dissemination of reactive scientific information and other activities performed by Medical Information
  • Collaborate with Safety and QA on the process for the receipt of post marketing adverse events and product quality complaints, ensure audit ready
  • Identify, implement, and lead the oversight of the Medical Information call center(s) that will cover the necessary geographies, aligning with and integrating standards, processes, and technology
  • Contribute to congress planning and on-site representation associated with the medical affairs and medical information presence
  • Develop and maintain Medical Information materials, including standard response documents, FAQs and scientific content
  • Review and approve promotional and non-promotional materials for accuracy as a member of the Medical Review Committee and Promotional Review Committee
  • Create informative dashboards to track and communicate Medical Information activities to leadership and cross-functional business partners, identifying and trends or data gaps
  • Collaborate with HEOR on the development of the AMCP and Global Value Dossiers with scientific data input and reviews
  • Create a process of the submission of unsolicited requests for medical information and train internal colleagues on this process

Minimum Requirements

  • Advanced Clinical/Scientific degree required (Pharm.D. or Ph.D preferred)
  • 8+ years of experience in medical information and/or relevant experience in the pharmaceutical industry
  • Hematology/Oncology therapeutic area experience and knowledge required, cell therapy experience preferred
  • Experience on promotional and medical review committee
  • Experience managing an external call center
  • Working knowledge of legal and regulatory guidelines in the pharmaceutical industry
  • Strong computer and technical skills with proficiency in various technology platforms, such as Medical Information database systems, SharePoint, Veeva, PowerPoint, etc.

Who We Are

  • We are driven by a passion for science and compassion for patients.
  • We act with urgency to ensure our treatments are one day accessible to all who need them.
  • We live by our core values of passion, courage, and integrity.
  • Excellence in our work means the chance to unlock a better quality of life for our patients, and with that comes tremendous responsibility.
  • We innovate on a path that hasn’t been paved.
  • We embrace an entrepreneurial spirit and take calculated risks to achieve our mission.
  • We aren’t afraid to ask “why not” and challenge the status quo.
  • We maintain a start-up culture of camaraderie and leadership by example, regardless of title.

Skills

Medical Information
Medical Affairs
Biotechnology
Cell Therapy
Budget Management
Business Process
Scientific Information Dissemination
Adverse Event Reporting
Product Quality Complaints
Call Center Management
Congress Planning
On-site Representation

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI